196 related articles for article (PubMed ID: 20033474)
1. Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.
Ghalanbor Z; Körber M; Bodmeier R
Pharm Res; 2010 Feb; 27(2):371-9. PubMed ID: 20033474
[TBL] [Abstract][Full Text] [Related]
2. Production of Lysozyme-PLGA-Loaded Microparticles for Controlled Release Using Hot-Melt Extrusion.
Farinha S; Moura C; Afonso MD; Henriques J
AAPS PharmSciTech; 2020 Oct; 21(7):274. PubMed ID: 33033873
[TBL] [Abstract][Full Text] [Related]
3. Protein release from poly(lactide-co-glycolide) implants prepared by hot-melt extrusion: thioester formation as a reason for incomplete release.
Ghalanbor Z; Körber M; Bodmeier R
Int J Pharm; 2012 Nov; 438(1-2):302-6. PubMed ID: 22989984
[TBL] [Abstract][Full Text] [Related]
4. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
[TBL] [Abstract][Full Text] [Related]
5. Manufacturing of Dexamethasone-Poly(d,l-Lactide-co-Glycolide) Implants Using Hot-Melt Extrusion: Within- and Between-Batch Product Performance Comparisons.
Kelley RA; Ghaffari A; Wang Y; Choi S; Taylor JR; Hartman RR; Kompella UB
J Ocul Pharmacol Ther; 2020 Jun; 36(5):290-297. PubMed ID: 32330403
[No Abstract] [Full Text] [Related]
6. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization.
Porjazoska A; Goracinova K; Mladenovska K; Glavas M; Simonovska M; Janjević EI; Cvetkovska M
Acta Pharm; 2004 Sep; 54(3):215-29. PubMed ID: 15610618
[TBL] [Abstract][Full Text] [Related]
7. Hot Melt Extrusion for Sustained Protein Release: Matrix Erosion and In Vitro Release of PLGA-Based Implants.
Cossé A; König C; Lamprecht A; Wagner KG
AAPS PharmSciTech; 2017 Jan; 18(1):15-26. PubMed ID: 27193002
[TBL] [Abstract][Full Text] [Related]
8. Improving release completeness from PLGA-based implants for the acid-labile model protein ovalbumin.
Duque L; Körber M; Bodmeier R
Int J Pharm; 2018 Mar; 538(1-2):139-146. PubMed ID: 29355654
[TBL] [Abstract][Full Text] [Related]
9. Lysozyme release and polymer erosion behavior of injectable implants prepared from PLGA-PEG block copolymers and PLGA/PLGA-PEG blends.
Vesna Milacic VM; Schwendeman SP
Pharm Res; 2014 Feb; 31(2):436-48. PubMed ID: 23959854
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of a novel bioactive glass/lysozyme/PLGA composite microsphere.
Liu H; Shi S; Cao J; Ji L; He Y; Xi J
Drug Dev Ind Pharm; 2015 Mar; 41(3):458-63. PubMed ID: 24471512
[TBL] [Abstract][Full Text] [Related]
11. Trehalose limits BSA aggregation in spray-dried formulations at high temperatures: implications in preparing polymer implants for long-term protein delivery.
Rajagopal K; Wood J; Tran B; Patapoff TW; Nivaggioli T
J Pharm Sci; 2013 Aug; 102(8):2655-66. PubMed ID: 23754501
[TBL] [Abstract][Full Text] [Related]
12. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
13. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying.
Quaglia F; De Rosa G; Granata E; Ungaro F; Fattal E; Immacolata La Rotonda M
J Control Release; 2003 Jan; 86(2-3):267-78. PubMed ID: 12526823
[TBL] [Abstract][Full Text] [Related]
14. PLGA-based monolithic filaments prepared by hot-melt extrusion: In-vitro comparative study.
Kamel R; Abbas H
Ann Pharm Fr; 2018 Mar; 76(2):97-106. PubMed ID: 29145995
[TBL] [Abstract][Full Text] [Related]
15. Influence of PLGA End Groups on the Release Profile of Dexamethasone from Ocular Implants.
Saraf I; Kushwah V; Alva C; Koutsamanis I; Rattenberger J; Schroettner H; Mayrhofer C; Modhave D; Braun M; Werner B; Zangger K; Paudel A
Mol Pharm; 2023 Feb; 20(2):1307-1322. PubMed ID: 36680524
[TBL] [Abstract][Full Text] [Related]
16. Towards the optimization of drug delivery to the cochlear apex: Influence of polymer and drug selection in biodegradable intracochlear implants.
Lehner E; Honeder C; Knolle W; Binder W; Scheffler J; Plontke SK; Liebau A; Mäder K
Int J Pharm; 2023 Aug; 643():123268. PubMed ID: 37488058
[TBL] [Abstract][Full Text] [Related]
17. Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.
Guo Y; Yang Y; He L; Sun R; Pu C; Xie B; He H; Zhang Y; Yin T; Wang Y; Tang X
Pharm Res; 2017 Oct; 34(10):2211-2222. PubMed ID: 28741064
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704
[TBL] [Abstract][Full Text] [Related]
20. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
Duan Y; Sun X; Gong T; Wang Q; Zhang Z
J Mater Sci Mater Med; 2006 Jun; 17(6):509-16. PubMed ID: 16691348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
